Germany · Delayed Price · Currency is EUR K+S Aktiengesellschaft Earnings Call Transcripts
Fiscal Year 2026
-
Q1 EBITDA surged 40% year-over-year to nearly EUR 280 million, driven by strong de-icing salt and agriculture sales. Full-year EBITDA guidance was raised to EUR 630–730 million, with robust global potash demand and stable specialty product pricing supporting the outlook.
Fiscal Year 2025
-
Q4 EBITDA rose 17% year-over-year, with strong potash and de-icing salt demand driving results. 2026 EBITDA is guided at EUR 600–700 million, supported by higher prices and robust global demand, while risks from logistics and energy costs are expected to be offset by pricing.
-
Q3 EBITDA and free cash flow improved year-over-year, driven by better pricing and FX effects. Full-year EBITDA guidance is confirmed, with stable costs and modest volume growth expected for 2026. Specialty product mix and stable salt pricing support performance.
-
Q2 results were impacted by a EUR 2 billion asset impairment due to FX changes, but full-year EBITDA guidance of EUR 560–620 million and a positive free cash flow outlook were maintained. Potash demand remains strong, with stable prices expected and supply-demand balance projected for 2026.
-
Q1 results exceeded expectations due to higher potash prices, strong production, and positive inventory effects. Full-year EBITDA guidance was raised, with strong global demand and low inventories supporting favorable pricing. Working capital and personnel costs are expected to rise.
Fiscal Year 2024
-
EBITDA for 2024 reached EUR 558 million, with free cash flow of EUR 62 million, and 2025 guidance projects similar EBITDA amid strong global demand and tight supply. Elevated CapEx continues, but free cash flow is expected to at least break even.
-
Q3 results were robust, with strong specialty and salt business performance offsetting lower prices. Full-year EBITDA is guided to the lower end of the range due to production bottlenecks, but free cash flow remains positive. SOP prices and demand outlook for 2025 are strong.
-
Q2 2024 saw strong EBITDA growth and robust demand, with full-year guidance narrowed and elevated CapEx through 2027 for strategic projects. European and specialty segments outperformed, and favorable market conditions are expected to persist into 2025.